[1]
Faruk, O. et al. 2024. Development of a Sustained-Release Oral Tablet of Tyrosine Kinase Inhibitor Imatinib Using Full Factorial Design. Dhaka University Journal of Pharmaceutical Sciences. 23, 2 (Dec. 2024), 135–143. DOI:https://doi.org/10.3329/dujps.v23i2.78571.